Molecule Details
| InChIKey | GHDKYBCUDPSXGJ-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-((3-Bromo-4-O-sulfamoylbenzyl)(4-cyanophenyl)amino)-4H-(1,2,4)-triazole |
| Canonical SMILES | N#Cc1ccc(N(Cc2ccc(OS(N)(=O)=O)c(Br)c2)n2cnnc2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.79 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB04600 |
|---|---|
| Drug Name | 4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE |
| CAS Number | nan |
| Groups | experimental |
| ATC Codes | nan |
| Description | nan |
Cross-references: BindingDB: 10020 CHEMBL108483 ChemSpider: 3571981 PDB: 4TR PubChem:4369414 PubChem:46508682 ZINC: ZINC000003991718
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P00918 | CA2 | Carbonic anhydrase 2 | binder | targets |